• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[单独使用奎奴普丁-达福普汀或与庆大霉素、替考拉宁、亚胺培南或左氧氟沙星联合治疗耐多药粪肠球菌所致实验性心内膜炎的比较研究]

[Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].

作者信息

Pérez Salmerón J, Martínez García F, Roldán Conesa D, Lorente Salinas I, López Fornás F, Ruiz Gómez J, Gómez Gómez J, Segovia Hernández M, Valdés Chávarri M

机构信息

Servicios de Cardiologia y Microbiologia, Hospital Universitario Virgen de la Arrixaca, 30005 Murcia, Spain.

出版信息

Rev Esp Quimioter. 2006 Sep;19(3):258-66.

PMID:17099794
Abstract

The incidence of multidrug-resistant Enterococcus faecium is increasing despite advances in antibacterial therapy. Thus, new antibiotics are required to treat hospital- or community-acquired infections caused by these multidrug-resistant organisms. The aim of this study was to compare the therapeutic efficacy of quinupristin-dalfopristin (QD) alone, or in combination with gentamicin (G), teicoplanin (T), imipenem (I) or levofloxacin (L) against a strain of multidrug-resistant E. faecium in an experimental model of aortic valve endocarditis in rabbits. The study group consisted of 28 control animals. Eighty-two animals were treated with one of the following antibiotic regimens: G1: 18 animals QD (30 mg/kg/8 h); G2: 18 animals QD+G (6 mg/kg/12 h); G3: 16 animals QD+T (20 mg/kg/12 h); G4: 14 animals QD+I (60 mg/kg/8 h); and G5: 16 animals QD+L (20 mg/kg/12 h). The response to therapy was determined by the comparison of the number of CFU/g of E. faecium in each vegetation. In vitro, time-kill studies looking for synergy for the combinations that showed better efficacy in vivo were done. The sensitivity of the strain was intermediate to QD, resistant to T and I, and sensitive to L. There was no high-level resistance to G. QD alone revealed a significant decrease (p <0.001) in the CFU/g in the control group (9.49 vs. 7.31). There were no differences in the average of CFU/g between the QD alone (G1), QD+G (G2) and QD+T (G3) groups. These three groups revealed a significant difference in decrease of CFU/g respect of the group control (p <0.001). There were no differences in the average of CFU/g between QD+I (G4) and QD+T (G5). These two groups revealed the greatest decrease in average CFU/g (G4: 4.38 and G5: 4.04) with differences respect of the group control (p <0.0001) and respect of the groups G1, G2 and G3 (p <0.001). We did not detect any alteration of MIC from QD in the course of the treatment for either of the final isolations. Only the time kill corresponding to concentrations of I 32 mg/l (0.25 x MIC) and QD 1 mg/l (0.25 x MIC presents a descending slope in the curve at 4 and 8 h, suggesting an early synergy phenomenon, which was lost after 8 h. In light of these results, the combination QD with I and L may be considered suitable alternatives for the treatment of multiresistant E. faecium.

摘要

尽管抗菌治疗取得了进展,但耐多药屎肠球菌的发病率仍在上升。因此,需要新的抗生素来治疗由这些耐多药微生物引起的医院获得性或社区获得性感染。本研究的目的是在兔主动脉瓣心内膜炎实验模型中,比较单独使用奎奴普丁-达福普汀(QD)或与庆大霉素(G)、替考拉宁(T)、亚胺培南(I)或左氧氟沙星(L)联合使用对一株耐多药屎肠球菌的治疗效果。研究组包括28只对照动物。82只动物接受了以下抗生素治疗方案之一:G1:18只动物使用QD(30mg/kg/8小时);G2:18只动物使用QD+G(6mg/kg/12小时);G3:16只动物使用QD+T(20mg/kg/12小时);G4:14只动物使用QD+I(60mg/kg/8小时);G5:16只动物使用QD+L(20mg/kg/12小时)。通过比较每个赘生物中每克屎肠球菌的CFU数量来确定治疗反应。在体外,对体内显示出更好疗效的组合进行了时间杀菌研究以寻找协同作用。该菌株对QD的敏感性为中度,对T和I耐药,对L敏感。对G没有高水平耐药。单独使用QD时,对照组的CFU/g显著降低(p<0.001)(9.49对7.31)。单独使用QD(G1)、QD+G(G2)和QD+T(G3)组之间每克CFU的平均值没有差异。这三组与对照组相比,CFU/g的降低有显著差异(p<0.001)。QD+I(G4)和QD+T(G5)组之间每克CFU的平均值没有差异。这两组每克CFU的平均值下降最大(G4:4.38和G5:4.04),与对照组相比有差异(p<0.0001),与G1、G2和G3组相比有差异(p<0.001)。在最终分离的任何一种情况下,我们都未检测到QD的MIC有任何变化。只有对应于I浓度为32mg/l(0.25xMIC)和QD浓度为1mg/l(0.25xMIC)的时间杀菌曲线在4小时和8小时出现下降斜率,表明早期协同现象,8小时后消失。鉴于这些结果,QD与I和L的联合使用可能被认为是治疗耐多药屎肠球菌的合适替代方案。

相似文献

1
[Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].[单独使用奎奴普丁-达福普汀或与庆大霉素、替考拉宁、亚胺培南或左氧氟沙星联合治疗耐多药粪肠球菌所致实验性心内膜炎的比较研究]
Rev Esp Quimioter. 2006 Sep;19(3):258-66.
2
Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.奎奴普丁/达福普汀治疗耐万古霉素屎肠球菌感染。
Clin Infect Dis. 2000 May;30(5):790-7. doi: 10.1086/313766. Epub 2000 May 18.
3
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.达托霉素治疗由敏感及耐多药肠球菌引起的实验性心内膜炎的疗效。
J Antimicrob Chemother. 2006 Dec;58(6):1208-14. doi: 10.1093/jac/dkl406. Epub 2006 Oct 9.
4
Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.低水平万古霉素耐药对替考拉宁和万古霉素治疗粪肠球菌所致实验性心内膜炎疗效的影响。
Antimicrob Agents Chemother. 1991 Aug;35(8):1570-5. doi: 10.1128/AAC.35.8.1570.
5
Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.基于人体药代动力学的替考拉宁-庆大霉素每日一次给药方案治疗肠球菌性实验性心内膜炎的疗效。
Antimicrob Agents Chemother. 2001 May;45(5):1387-93. doi: 10.1128/AAC.45.5.1387-1393.2001.
6
Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.单独使用或与万古霉素联合使用的奎奴普丁/达福普汀对粪肠球菌结构的影响。
Drugs Exp Clin Res. 1998;24(2):73-6.
7
In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.奎奴普丁/达福普汀及其他抗生素对耐氨苄西林屎肠球菌的体外活性
Zhonghua Yi Xue Za Zhi (Taipei). 2000 Feb;63(2):119-23.
8
Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.用不同剂量替考拉宁治疗由耐青霉素血链球菌引起的实验性心内膜炎。
Methods Find Exp Clin Pharmacol. 1994 May;16(4):247-51.
9
Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin.多药耐药粪肠球菌性心内膜炎采用替加环素联合高剂量达托霉素治疗。
Ann Pharmacother. 2009 Dec;43(12):2108-12. doi: 10.1345/aph.1M324. Epub 2009 Nov 3.
10
Quinupristin-dalfopristin and linezolid: evidence and opinion.奎奴普丁-达福普汀与利奈唑胺:证据与观点。
Clin Infect Dis. 2003 Feb 15;36(4):473-81. doi: 10.1086/367662. Epub 2003 Jan 31.

引用本文的文献

1
What's New in the Treatment of Enterococcal Endocarditis?肠球菌性心内膜炎的治疗新进展?
Curr Infect Dis Rep. 2014 Oct;16(10):431. doi: 10.1007/s11908-014-0431-z.
2
Endocarditis caused by resistant enterococcus: an overview.耐万古霉素肠球菌引起的心内膜炎:概述。
Curr Infect Dis Rep. 2013 Aug;15(4):320-8. doi: 10.1007/s11908-013-0348-y.
3
Enterococcal endocarditis: can we win the war?肠球菌性心内膜炎:我们能否赢得这场战争?
Curr Infect Dis Rep. 2012 Aug;14(4):339-49. doi: 10.1007/s11908-012-0270-8.